Search

Freddie Kirkland Iii

Examiner (ID: 290)

Most Active Art Unit
2855
Art Unit(s)
2855, 2856
Total Applications
1942
Issued Applications
1671
Pending Applications
84
Abandoned Applications
212

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10987412 [patent_doc_number] => 20160184358 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2016-06-30 [patent_title] => 'BOWEL CLEANSING COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/724931 [patent_app_country] => US [patent_app_date] => 2012-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2320 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13724931 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/724931
BOWEL CLEANSING COMPOSITION Dec 20, 2012 Abandoned
Array ( [id] => 9175476 [patent_doc_number] => 20130317461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-28 [patent_title] => 'COMPOSITIONS AND METHODS FOR DELIVERING ESTRADIOL IN TRANSDERMAL DRUG DELIVERY SYSTEMS' [patent_app_type] => utility [patent_app_number] => 13/715276 [patent_app_country] => US [patent_app_date] => 2012-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9364 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13715276 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/715276
Compositions and methods for delivering active agents in transdermal drug delivery systems Dec 13, 2012 Issued
Array ( [id] => 8900335 [patent_doc_number] => 20130167838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-04 [patent_title] => 'NASAL FORMULATION' [patent_app_type] => utility [patent_app_number] => 13/708314 [patent_app_country] => US [patent_app_date] => 2012-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4329 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13708314 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/708314
NASAL FORMULATION Dec 6, 2012 Abandoned
Array ( [id] => 9838585 [patent_doc_number] => 20150030666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'ADHESIVE SKIN PATCH' [patent_app_type] => utility [patent_app_number] => 14/360831 [patent_app_country] => US [patent_app_date] => 2012-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17264 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14360831 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/360831
ADHESIVE SKIN PATCH Nov 27, 2012 Abandoned
Array ( [id] => 10919310 [patent_doc_number] => 20140322327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'DRUG DELIVERY SYSTEM FOR SUSTAINED DELIVERY OF BIOACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 14/358141 [patent_app_country] => US [patent_app_date] => 2012-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16373 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358141 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/358141
Drug delivery system for sustained delivery of bioactive agents Nov 14, 2012 Issued
Array ( [id] => 8707588 [patent_doc_number] => 20130064877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'COMPOSITION FOR THE TRANSDERMAL DELIVERY OF FENTANYL' [patent_app_type] => utility [patent_app_number] => 13/672057 [patent_app_country] => US [patent_app_date] => 2012-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13041 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13672057 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/672057
COMPOSITION FOR THE TRANSDERMAL DELIVERY OF FENTANYL Nov 7, 2012 Abandoned
Array ( [id] => 9736084 [patent_doc_number] => 20140271796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'OXYBUTYNIN-CONTAINING TRANSDERMAL ABSORPTION PREPARATION' [patent_app_type] => utility [patent_app_number] => 14/354151 [patent_app_country] => US [patent_app_date] => 2012-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6206 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354151 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/354151
OXYBUTYNIN-CONTAINING TRANSDERMAL ABSORPTION PREPARATION Oct 22, 2012 Abandoned
Array ( [id] => 8779572 [patent_doc_number] => 20130101547 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-25 [patent_title] => 'THERMORESPONSIVE COMPOSITIONS FOR DERMATOLOGICAL USE AND METHODS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/653271 [patent_app_country] => US [patent_app_date] => 2012-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40215 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13653271 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/653271
THERMORESPONSIVE COMPOSITIONS FOR DERMATOLOGICAL USE AND METHODS THEREOF Oct 15, 2012 Abandoned
Array ( [id] => 9687001 [patent_doc_number] => 20140243765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-28 [patent_title] => 'PERCUTANEOUSLY ABSORBABLE PREPARATION CONTAINING FENTANYL AND HOMOLOGUE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/346031 [patent_app_country] => US [patent_app_date] => 2012-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6868 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14346031 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/346031
PERCUTANEOUSLY ABSORBABLE PREPARATION CONTAINING FENTANYL AND HOMOLOGUE THEREOF Sep 20, 2012 Abandoned
Array ( [id] => 10938962 [patent_doc_number] => 20140341983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'SMART™ SOLID ORAL DOSAGE FORMS' [patent_app_type] => utility [patent_app_number] => 14/344221 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 17555 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344221 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/344221
SMARTâ„¢ SOLID ORAL DOSAGE FORMS Sep 13, 2012 Abandoned
Array ( [id] => 9771283 [patent_doc_number] => 20140294947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-02 [patent_title] => 'TAMPER RESISTANT IMMEDIATE RELEASE FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 14/344271 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11968 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344271 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/344271
TAMPER RESISTANT IMMEDIATE RELEASE FORMULATIONS Sep 13, 2012 Abandoned
Array ( [id] => 9615793 [patent_doc_number] => 20140205650 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'COATED SUPPOSITORIES' [patent_app_type] => utility [patent_app_number] => 14/342931 [patent_app_country] => US [patent_app_date] => 2012-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6637 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342931 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/342931
COATED SUPPOSITORIES Sep 5, 2012 Abandoned
Array ( [id] => 16381343 [patent_doc_number] => 10806149 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-20 [patent_title] => Method for producing silver-ion antibacterial liquid, silver-ion antibacterial liquid produced by said method, method for producing silver-ion antibacterial powder, and silver-ion antibacterial powder produced by said method [patent_app_type] => utility [patent_app_number] => 14/342210 [patent_app_country] => US [patent_app_date] => 2012-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 9739 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 224 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342210 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/342210
Method for producing silver-ion antibacterial liquid, silver-ion antibacterial liquid produced by said method, method for producing silver-ion antibacterial powder, and silver-ion antibacterial powder produced by said method Aug 30, 2012 Issued
Array ( [id] => 14388251 [patent_doc_number] => 10307382 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-04 [patent_title] => Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride [patent_app_type] => utility [patent_app_number] => 14/240810 [patent_app_country] => US [patent_app_date] => 2012-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3534 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240810 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/240810
Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride Aug 23, 2012 Issued
Array ( [id] => 10925889 [patent_doc_number] => 20140328908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'CONTROLLED-RELEASE FORMULATION' [patent_app_type] => utility [patent_app_number] => 14/238961 [patent_app_country] => US [patent_app_date] => 2012-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 33026 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238961 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/238961
Milrinone controlled-release formulation Aug 15, 2012 Issued
Array ( [id] => 8943783 [patent_doc_number] => 08496959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-30 [patent_title] => 'Method of promoting new tissue growth and/or wound healing using bioresorbable dressing comprising microspheres or microparticles' [patent_app_type] => utility [patent_app_number] => 13/584373 [patent_app_country] => US [patent_app_date] => 2012-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 10982 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13584373 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/584373
Method of promoting new tissue growth and/or wound healing using bioresorbable dressing comprising microspheres or microparticles Aug 12, 2012 Issued
Array ( [id] => 9546849 [patent_doc_number] => 20140171497 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUABLE MONENSIN AND METHODS THEREFOR' [patent_app_type] => utility [patent_app_number] => 14/232691 [patent_app_country] => US [patent_app_date] => 2012-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7780 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14232691 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/232691
ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUABLE MONENSIN AND METHODS THEREFOR Jul 25, 2012 Abandoned
Array ( [id] => 8613025 [patent_doc_number] => 20130018337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-17 [patent_title] => 'DERMAL DELIVERY DEVICE WITH IN SITU SEAL' [patent_app_type] => utility [patent_app_number] => 13/553362 [patent_app_country] => US [patent_app_date] => 2012-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8353 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13553362 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/553362
Dermal delivery device with in situ seal Jul 18, 2012 Issued
Array ( [id] => 8482914 [patent_doc_number] => 20120282321 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering' [patent_app_type] => utility [patent_app_number] => 13/553248 [patent_app_country] => US [patent_app_date] => 2012-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7922 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13553248 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/553248
Wound Dressings Containing Complexes of Transition Metals and Alginate for Elastase-Sequestering Jul 18, 2012 Abandoned
Array ( [id] => 8452834 [patent_doc_number] => 20120263780 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same' [patent_app_type] => utility [patent_app_number] => 13/534028 [patent_app_country] => US [patent_app_date] => 2012-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8059 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13534028 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/534028
Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same Jun 26, 2012 Abandoned
Menu